D. Osborne
Finanzdirektor/CFO bei Melt Pharmaceuticals, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Helen Sabzevari | M | 62 | 5 Jahre | |
| Larry Dillaha | M | 60 |
Melt Pharmaceuticals, Inc.
 Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | 3 Jahre |
| Jeffrey Perez | M | 52 | 10 Jahre | |
| Fred Hassan | M | 78 | 8 Jahre | |
| Jeffrey Kindler | M | 68 | 13 Jahre | |
| James Turley | M | 68 | 10 Jahre | |
| Vinita Deshbandhu Gupta | F | 56 | 7 Jahre | |
| Arthur Laffer | M | 83 |
Melt Pharmaceuticals, Inc.
Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | 2 Jahre |
| Mark Baum | M | 51 |
Melt Pharmaceuticals, Inc.
Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | - |
| J. Corley | M | 68 |
Melt Pharmaceuticals, Inc.
Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | 5 Jahre |
| Steven M. Harasym | M | - | 6 Jahre | |
| John Berdahl | M | - |
Melt Pharmaceuticals, Inc.
Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | - |
| Giovanni de Castro | M | - |
Melt Pharmaceuticals, Inc.
Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Samuel Broder | M | 79 | 2 Jahre | |
| Thomas David Reed | M | 58 | 22 Jahre | |
| Robert Beech | M | 71 | 8 Jahre | |
| Robert Shapiro | M | 85 | 12 Jahre | |
| Larry D. Horner | M | 90 | 7 Jahre | |
| Marie L. Rossi | M | - | 9 Jahre | |
| Thomas Shrader | M | - | - | |
| Olivier R. Jarry | M | 63 | - | |
| James Vincent Lambert | M | 60 | 1 Jahre | |
| Rick Sterling | M | 60 | 14 Jahre | |
| Jack Anthony Bobo | M | 58 | - | |
| Dana di Ferdinando | F | - | - | |
| Christopher Basta | M | - | - | |
| Kelly Huang | M | 55 | - | |
| Grace Colón | M | 57 | 2 Jahre | |
| Andy Bass | M | - | - | |
| Fayaz Khazi | M | 51 | 2 Jahre | |
| Thomas Bostick | M | 67 | 3 Jahre | |
| Timothy D. Kasbe | M | 58 | - | |
| Ena Chan Cratsenburg | F | - | - | |
| Jayson M. Rieger | M | 48 | 1 Jahre | |
| Nir Nimrodi | M | 55 | 5 Jahre | |
| Robert F. Walsh | M | 65 | 6 Jahre | |
| Geno Germano | M | 63 | 1 Jahre | |
| Matthew Crisp | M | 41 | 1 Jahre | |
| Peter Emtage | M | - | - | |
| Hadyn Parry | M | - | - | |
| Peter Seufer-Wasserthal | M | - | 5 Jahre | |
| Joel A. Liffmann | M | 63 | 4 Jahre | |
| Krish S. Krishnan | M | 59 | 5 Jahre | |
| Saiid Zarrabian | M | 71 | 1 Jahre | |
| Andrew Last | M | 64 | 1 Jahre | |
| Suma M. Krishnan | F | 59 | 4 Jahre | |
| Gregory Ian Frost | M | 52 | 1 Jahre | |
| Chris Savile | M | - | 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 48 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- D. Osborne
- Persönliches Netzwerk
